Home/Filings/4/0001628280-23-008357
4//SEC Filing

Smeal Tod 4

Accession 0001628280-23-008357

CIK 0001213037other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 5:42 PM ET

Size

5.5 KB

Accession

0001628280-23-008357

Insider Transaction Report

Form 4
Period: 2023-03-15
Smeal Tod
Chief Scientific Officer
Transactions
  • Award

    Stock Options

    2023-03-15+167,088442,176 total
    Exercise: $1.72Exp: 2033-03-15Common Stock (167,088 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001904824

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:42 PM ET
Size
5.5 KB